School of Pharmacy, Zhengzhou University makes new progress in the study of epigenetic pathogenesis of heart failure

25 August,2021
Share to

Recently, Professor Zhao Wen's team from the School of Pharmacy, Zhengzhou University has made new progress in the study of epigenetic pathogenesis of heart failure. The research results, titled “Myofibroblast Deficiency of LSD1 Alleviates TAC-induced Heart Failure”, has been published in Circulation Research, an international leading journal in the field of cardiovascular research. Huo Jinling, PhD student of the School of Pharmacy, is the first author. Prof. Zhao Wen, Prof. Wang Chung and Prof. Chen Dong of Capital Medical University are the co-corresponding authors.